Physician profile
Heather K Henig
NPI 1699983692
$3,157.27
in general payments reported to CMS, 2019-2025
19 companies · $18.25 in 2025
The $18.25 reported for 2025 was less than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,037 · 2020: $592 · 2021: $679 · 2022: $624 · 2023: $158 · 2024: $48.43 · 2025: $18.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $618.62 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $507.54 | 2019-2024 | Spravato |
| Allergan, INC. | $396.30 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $337.38 | 2019-2025 | Rexulti |
| Supernus Pharmaceuticals, INC. | $235.66 | 2021-2022 | |
| Lundbeck LLC | $205.82 | 2019-2023 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $128.55 | 2020-2023 | Trintellix |
| Tris Pharma INC | $128.13 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $125.00 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $96.87 | 2022 | |
| Abbvie INC. | $72.24 | 2021-2023 | |
| Shire North American Group INC | $65.68 | 2019 | |
| Alkermes, INC. | $56.33 | 2022-2023 | Aristada, Lybalvi |
| Bausch Health US, LLC | $55.92 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $50.01 | 2019-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $30.28 | 2024 | Azstarys |
| Vertical Pharmaceuticals, LLC | $22.26 | 2019 | |
| Adlon Therapeutics L.P. | $12.64 | 2021 | |
| Owp Pharmaceuticals, INC. | $12.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Henig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.